Lecture 7 Flashcards

1
Q

Receptors can be i_________ or e___________

Steroid hromones are l_________

A

intracellular or extracellular

lipophillic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is signal transduction?

A

Signal transduction is the process by which a chemical or physical signal is transmitted through a cell as a series of molecular events, most commonly protein phosphorylation catalyzed by protein kinases, which ultimately results in a cellular response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Give examples of drugs that are agonists and work on beta-2 adrenoreceptors

A

Salbutomol and salmeterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Give examples of drugs that are agonists on u-opioid receptors

A

Morphine, heroin, fentanyl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are G proteins made up of?

A

They are heterotrimeric. They are made up of 3 subunits:

  • alpha (attached to a GDP)
  • beta
  • gamma (y)

(beta and gamma don’t seperate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Beta-2 adrenoreceptor structure - show it’s 3 subunits

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Recap G protein-coupled recptors structure

A
  • Single polypeptide chain (300-1200 amino acids)
  • 7-transmembrane (7TM)- spanning regions
  • Extracellular N-terminal
  • Intracellular C-terminal

Binding domains: there are 2

  • For some receptors the ligand binding site is formed by (2-3 of) the transmembrane (TM) domains
  • In other cases the N-terminal region (and other extracellular domains) form the ligand binding site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How GPCR work as a receptor?

A
  • Ligand binds to the binding domain
  • Causes a conformational change
  • This leads to the activation of G proteins by causing the GDP to exchange for GTP on the G protein alpha subunit
  • The alpha-beta-gamma complex immediately dissociates into alpha GTP and free beta-gamma subunits. Each can then interact with effector proteins (second-messenger generating enzymes or ion channels)

Note - this is actually happening much closer to the plasma membrane, this is becuase the alpha-GTP and beta-gamma are always associated with the cell membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Termination of G-protein signalling

A

The α-GTP and/or βγ interaction with effectors lasts until the α subunit GTPase activity hydrolyses GTP back to GDP. α-GDP and βγ subunits then reform an inactive heterotrimeric complex.

‘I’ for inactive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Summary of the G-protein cycle (activated -> inactivated -> activated… etc)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

G protein diversity

A

The human genome encodes 18 Gα (alpha), 5 Gβ (beta) and 12 Gγ (gamma) proteins Therefore, there are >1000 possible Gα-βγ protein combinations.

Activated GPCRs preferentially interact with specific types of G protein. The Gα subunit is a primary determinant.

In turn, Gα subunits and Gβγ subunits interact with specific effector proteins.

WE NEED TO KNOW ABOUT 3 SPECIFIC TYPES OF G PROTEINS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

3 types of G proteins we need to know about?

A

s – stimulates adenylyl cyclase
i – inhibits adenylyl cyclase
q – stimulates phospholipase C

THIS RELATES TO QISS QIQ (cover later!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The GPCR receptors in the autonomic nervous system -
Sympathetic and parasympathetic

list receptor, Gα protein type and effector

A

QISS QIQ

Adrenergic Sympathetic receptors:

α1 Gαq Stimulate Phosholipase C
α2 Gα<span>i </span> Inhibit Adenylyl Cyclase
β1 Gα<span>S</span> Stimulate Adenylyl Cyclase
β2 Gα<span>S</span> Stimulate Adenylyl Cyclase

Cholinergic Parasympathetic receptors:

M1 Gαq Stimulate Phospholipase C
M2 Gα<span>i </span>Inhibit Adenylyl Cyclase
M3 Gαq Stimulate Phospholipase C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Whooping cough - another name for this
What happens?

A

Pertussis

  • interferes and modifies Gαi
  • This means that the Gαi can no longer undergo GTP to GDP exchange, therefore the G protein can’t be activated, nothing after this step can then occur

“A component of the toxin (known as pertussis toxin) produced by this bacterium acts to ADP-ribosylate Gαi proteins locking them in their inactive GDP bound form.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cholera

A

Cholera toxin (CTx) prevents termination of signalling by Gs -preferring GPCRs leading to longlasting activation of downstream pathways

● Is does this as the bacterium acts to ADP-ribosylate Gαs proteins locking them in their active form
● Since there is more alpha(S)-GTP this will go to phosphorylate adenylyl cyclase which converts ATP→ cAMP
● The increase in cAMP in enterocytes (small intestine epithelia) causes the stimulation of CFTR transporter which pumps more Cl- ions into the lumen causing the loss of water down the osmotic gradient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Where is 99% of the human bodies 1kg of calcium found?
What is the serum levels of Ca2+ in the body?
How is whole body Ca2+ homeostasis regulated?

A
  • 99%: In bone
  • Blood serium: 1.9-2.3mM of which 50% is free Ca2+
  • Regulated: by intestinal Ca2+ uptake (from diet), Ca2+ reabsorption in kidneys and bone calcium regulation
  • these are under endocrine control.
17
Q

What kind of processes are changes in IC Ca2+ responsible for?

A

Muscle contraction, neurotransmission, fertilisation, cell death, learning and memory.

18
Q

By what mechanisms are Ca2+ gradients set up and maintained?

A
  • Relative permeability of plasma membrane to Ca2+ (Ca2+ doesn’t leak across the membrane)
  • Pumps and transporters that move Ca2+ out of the cytoplasm
  • Ca2+ buffer proteins.
  • -> PMCA (plasma membrane Ca2+-ATPase) and SERCA (endoplasmic reticulum Ca2+-ATPase) move Ca2+ out of the cytoplasm (this is against Ca2+ conc gradient, so uses ATP)
  • -> NCX moves Ca2+ out of the cell in exchange for Na+ (this is along Na+ conc gradient)
19
Q

Which mechanisms increase IC Ca2+?

A

Two ways to increase intracellular [Ca2+]:

  1. Ca2+ movement across the plasma membrane (‘influx’)
    - Ligand-gated ion channel (LGIC)
    - Voltage-operated Ca2+ channels (VOCC)
  2. Ca2+ movement out of the ER/SR (‘release’):
    - Inositol 1,4,5-trisphosphate receptors (IP3R)
    - Ca2+-induced Ca2+ release (CICR) = ryanodine receptors
20
Q

In summary - three parts for a GPCR response

A

GPCR -> G protein -> Effector

21
Q

Describe the signal pathway that occurs when Gs is activated.

A
  • Gs activated, GDP swapped for GTP
  • alpha and beta/gamma subunits dissociate
  • Adenylyl cyclase activated, converts ATP into cAMP
  • cAMP activates PKA which phosphorylates target proteins within cell.
22
Q

Give 3 examples of receptors that are coupled to Gs and their associated ligands.

A

1) β-adrenoreceptors (adrenaline/noradrenaline) *think QISS QIQ*
2) D1-dopamine receptors (dopamine)
3) H2-histamine receptors (histamine)

23
Q

Describe the signal pathway that occurs when Gi is activated.

A
  • Gi activated, GDP swapped for GTP
  • Inhibits the activation of adenylyl cyclase
  • Less/no cAMP synthesised
  • Less/no activation of PKA, and therefore intracellular effects lacking.

AC in pic is adenyl cyclase

24
Q

Give 3 examples of receptors coupled to Gi and their associated ligands.

A

1) a2-adrenoreceptors (adrenaline) *think QISS QIQ*
2) D2-dopamine receptors (dopamine)
3) H1-histamine receptors (histamine)
4) M2/M4 mAChR’s (ACh) *think QISS QIQ*

25
Q

Describe the structure of PKA and how cAMP levels regulate its activity.

A
  • 2 regulatory subunits (R subunit) attached to 2 catalytic sub-units (S subunit)

PKA - cyclic AMP-dependent protein kinase

  • When cAMP is low, regulatory subunits and catalytic subunits have high affinity for each other, stay bound and inhibit activity of catalytic subunits
  • When cAMP is high, cAMP binds to R sub-units and catalytic subunits dissociate, leading to phosphorylation of target proteins.
26
Q

Describe the signal pathway that occurs when Gq is activated.

A

Phospholipase C (PLC): PIP2 -> IP3 + DAG

  • Gq activated, GDP swapped for GTP
  • Activated phospholipase C (PLC), causing phosphorylation of PIP2 into DAG and IP3
  • IP3 acts on IP3 receptors (IP3R) in ER, activating Ca2+ channel and entry of Ca2+ into cytoplasm
  • DAG remains in membrane, binds to PKC which phosphorylate’s key substrate proteins (different to the ones PKA phosphorylates
27
Q

Give 3 examples of receptors coupled to Gq and their associated ligands

A

1) a1-adrenoreceptors (adrenaline) *think QISS QIQ*
2) M1/M3/M5 mAChR’s (ACh) *think QISS QIQ*
3) H1 histamine receptors (histamine)

28
Q

Why is only a few molecules of ligand required to create a massive cellular response in GPCR’s?

A

SIGNAL AMPLIFICATION IS A KEY FEATURE OF MANY (BASCIALLY ALL) OF CELL SIGNALLING PATHWAYS -> Due to the large amplification effect that occurs
- the step from AC to cAMP is large amplification step, that means we don’t need to waste cellular energy providing large amounts of ligand for receptors.

29
Q

What is the effect of adrenaline binding to B1-adrenoreceptors in the heart on inotropy?

A
  • Activated Gs, activates adenyl cyclase, changes ATP into cAMP, increase cAMP activates more PKA (cyclic AMP-dependent protein kinase), PKA phosphorylates VOCC.
  • When VOCC are phosphoylated, it allows more Ca2+ to enter when the membrane next depolarises, therefore increases Ca2+ entry through cascade, increased contractility, and therefore a positive inotropic effect.

(Positive inotropes strengthen the force of the heartbeat)

30
Q

What is the effect of noradrenaline binding to a1-adrenoreceptors in smooth muscle

What is the effect of acetylcoholine binding to M3-muscarinic receptors in smooth muscle

A
  • Vasocontriction via the Gq signalling pathway (as this pathway results in a increasing Ca2+ concentration in the cytoplasm, so increasing contractility

Contraction of blood vessels:
Sympathetically released noradrenaline (and to some extent blood-borne adrenaline) can interact with vascular smooth muscle α1 -adrenoceptors to cause vasoconstriction

Contaction of airways:
Parasympathetically released acetylcholine can interact with bronchiolar smooth muscle M3 -muscarinic receptors to cause bronchoconstriction

31
Q

Regulation of neurotransmitter release using μ-opioid receptors

1- reminder of how calcium enters pre-synatpic neurone in an action potential

2- GPCR’S can be expressed closely with VOCC

3- GPCR’s modulating neurotransmitter release

A
  1. Depolarization of the nerve terminal activates voltage-operated Ca2+ channels (VOCC) that result in Ca2+ influx. This leads to synaptic vesicle fusion and neurotransmitter release.
  2. Particular subtypes of GPCR (e.g. µ-opioid receptors) are expressed in close proximity to the VOCCs and can regulate channel activity via a G protein-dependent mechanism
  3. In both the central (CNS) and peripheral (PNS) nervous systems neurotransmitter release is often modulated by presynaptic G protein-coupled receptors, they are lose to the specific VOCC found in the neurone.
    * *Gβγ** subunits inhibit specific types of voltage-operated Ca2+ channels (VOCCs) reducing Ca2+ -influx and neurotransmitter release (next time the VOCC is regulated by a change in membrane voltage, in the presence of βγ subunits, less calcium enters the nerve terminal so less vesicle fusion occurs, so less neurotransmitter is released into the synapse)
32
Q

Summary of GPCRs:

  • Diversity
  • Specificity
  • Amplification
A
  1. DIVERSITY: Multiple subtypes of receptors, G proteins and effectors (this diversity allows different effects)
  2. SPECIFICITY: Specific ligand-receptor interactions, specific G protein α-subunits (βγ) recruited, which are coupled to specific effector pathways. The same receptor results in the same transducing pathway, so the same physiological outcome is achieved.
  3. AMPLIFICATION: “Gain” control on all signalling pathways, allowing relatively small changes in extracellular signal to elicit physiologically significant changes in cellular behaviour.